CIK 0000811641 · Non-accelerated filer<br>Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010382980
- Phone
- 2078782770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-10 | BRIGHAM MICHAEL F President & CEO | Grant or award · Incentive stock options (right to buy) | +25,000 | $5.84 | $146K | 25,000 |
| 2017-02-10 | CRABB JOSEPH H Vice President and CSO | Grant or award · Incentive Stock Options | +1,000 | $5.84 | $6K | 1,000 |
| 2017-02-10 | Brockmann Bobbi Jo VP of Sales & Marketing | Grant or award · Incentive Stock Option (Right fo Buy) | +10,000 | $5.84 | $58K | 10,000 |
| 2016-11-07 | Tomsche David Scott Director | Purchase | +4,000 | $5.19 | $21K | 70,789 |
| 2016-09-19 | Cunningham David Director | Returned to the company | −7,334 | $7.83 | $57K | 2,070 |
| 2016-09-19 | Cunningham David Director | Option exercise | +10,000 | $5.75 | $58K | 12,070 |
| 2016-09-19 | Cunningham David Director | Option exercise · Non-qualified stock options (right to buy) | −10,000 | 0 | ||
| 2016-08-22 | Cunningham David Director | Purchase | −3,000 | $7.14 | $21K | 9,404 |
| 2016-08-19 | Cunningham David Director | Option exercise | +5,000 | $5.75 | $29K | 12,404 |
| 2016-08-19 | Cunningham David Director | Option exercise · Non-qualified stock options | −5,000 | $5.75 | $29K | 10,000 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −341 | $6.53 | $2K | 106,705 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −400 | $6.50 | $3K | 106,305 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −100 | $6.51 | $651 | 106,205 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −500 | $6.55 | $3K | 105,705 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −394 | $6.59 | $3K | 105,311 |
| 2016-07-08 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −200 | $6.60 | $1K | 105,111 |
| 2016-07-07 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −6 | $6.59 | $40 | 107,305 |
| 2016-07-07 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −200 | $6.53 | $1K | 107,105 |
| 2016-07-07 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −59 | $6.55 | $386 | 107,046 |
| 2016-07-06 | CRABB JOSEPH H VP & Chief Scientific Officer | Sale | −900 | $6.60 | $6K | 108,837 |
Page 9 of 11 · 209 trades